SCHEMBL18425099

SCHEMBL18425099

COC(=O)c1cc(S(N)(=O)=O)c(Cl)cc1NCc1ccccc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CISD1 Q9NZ45 6/20 0.78
▸ CA12 O43570 13/20 0.74
▸ CA1 P00915 13/20 0.74
▸ CA2 P00918 13/20 0.74
▸ CA9 Q16790 12/20 0.74
▸ CA6 P23280 12/20 0.74
▸ CA7 P43166 12/20 0.74
▸ CA14 Q9ULX7 12/20 0.74
▸ CA5B Q9Y2D0 11/20 0.74
▸ CA3 P07451 11/20 0.74
▸ CA13 Q8N1Q1 11/20 0.74
▸ CA5A P35218 10/20 0.74
▸ AQP1 P29972 1/20 0.63
▸ CA4 P22748 6/20 0.59
▸ ALDH1A1 P00352 1/20 0.55
▸ HTR1A P08908 1/20 0.55
▸ HSD11B1 P28845 1/20 0.55
▸ SLC10A1 Q14973 1/20 0.55
▸ GPR35 Q9HC97 1/20 0.55
▸ ABCG2 Q9UNQ0 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1716052 0.88 CISD1 (1.00) CISD1CA12CA1CA2CA9
SCHEMBL13545223 0.87 CISD1 (0.80) CISD1CA12CA1CA2CA9
SCHEMBL13543235 0.86 CISD1 (0.78) CISD1CA12CA1CA2CA9
SCHEMBL18425147 0.85 CA1 (1.00) CISD1CA12CA1CA2CA9
SCHEMBL18424857 0.85 CA1 (1.00) CISD1CA12CA1CA2CA9
SCHEMBL31670531 0.85 CA1 (1.00) CISD1CA12CA1CA2CA9
SCHEMBL230392 0.82 APP (0.79) CISD1CA12CA1CA2CA9
SCHEMBL18425356 0.81 CA12 (1.00) CISD1CA12CA1CA2CA9
SCHEMBL18424482 0.81 CA12 (1.00) CISD1CA12CA1CA2CA9
SCHEMBL12418658 0.81 CISD1 (0.81) CISD1CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3328833-B1 SELECTIVE INHIBITORS OF CARBONIC ANHYDRASE UNIV VILNIUS (LT) 2025-08-06 — — EP claimed
US-20180222856-A1 SELECTIVE INHIBITORS OF CARBONIC ANHYDRASE VILNIUS UNIVERSITY (LT) 2018-08-09 — — US claimed
EP-3328833-A1 SELECTIVE INHIBITORS OF CARBONIC ANHYDRASE Vilnius University (LT) 2018-06-06 — — EP claimed
WO-2017017505-A1 SELECTIVE INHIBITORS OF CARBONIC ANHYDRASE VILNIUS UNIVERSITY (LT) 2017-02-02 — — WO claimed
EP-3328833-B1 SELECTIVE INHIBITORS OF CARBONIC ANHYDRASE UNIV VILNIUS (LT) 2025-08-06 — — EP disclosed
US-11312682-B2 Selective inhibitors of carbonic anhydrase VILNIUS UNIVERSITY (LT) 2022-04-26 — — US disclosed
US-20180222856-A1 SELECTIVE INHIBITORS OF CARBONIC ANHYDRASE VILNIUS UNIVERSITY (LT) 2018-08-09 — — US disclosed
EP-3328833-A1 SELECTIVE INHIBITORS OF CARBONIC ANHYDRASE Vilnius University (LT) 2018-06-06 — — EP disclosed
WO-2017017505-A1 SELECTIVE INHIBITORS OF CARBONIC ANHYDRASE VILNIUS UNIVERSITY (LT) 2017-02-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11312682-B2 Selective inhibitors of carbonic anhydrase CA2, CA9, CA7 CISD1 1710/4885CA12 8/4885CA1 6/4885
US-20180222856-A1 SELECTIVE INHIBITORS OF CARBONIC ANHYDRASE CA9, CA2, CA7 CISD1 1577/4885CA12 8/4885CA1 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback